Skip to main content

Blog

EUDAMED Vigilance Requirements and Steps

|
One of the modules of EUDAMED is Vigilance and Market Surveillance. EUDAMED will become mandatory for device Actors, Vigilance, Clinical Investigation/Performance Studies and Market Surveillance M…

How Device Companies Can Drive Regulatory Digitization

The last few years have brought unprecedented challenges, opportunities, and evolution for companies of all sizes. The small and middle market is no exception. In fact, the pandemic served as an a…

Benefits of IRT in Decentralized and Hybrid Clinical Trials

|
In recent years, decentralized and hybrid clinical trials have emerged as promising alternatives to traditional clinical trials. Decentralized clinical trials (DCTs) refer to studies in which part…

Singapore UDI Phase – 1 Implementation

|
The Health Sciences Authority of Singapore will implement the UDI system, a global system for tracking and identifying medical devices. The core components of Singapore’s UDI system are in accorda…

Automation: What Regulatory Team Needs to Know Before Investing

|
In recent years, Automaton has become more powerful and its applications to business have increased dramatically. As a result, companies and business functions, including Regulatory, that hadn’t s…